• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛β细胞 IL-22 受体缺陷导致胰岛素生物合成和全身葡萄糖稳态的年龄依赖性失调。

Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis.

机构信息

Immunopathology Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia.

Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.

出版信息

Nat Commun. 2024 May 29;15(1):4527. doi: 10.1038/s41467-024-48320-2.

DOI:10.1038/s41467-024-48320-2
PMID:38811550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11137127/
Abstract

The IL-22RA1 receptor is highly expressed in the pancreas, and exogenous IL-22 has been shown to reduce endoplasmic reticulum and oxidative stress in human pancreatic islets and promote secretion of high-quality insulin from beta-cells. However, the endogenous role of IL-22RA1 signaling on these cells remains unclear. Here, we show that antibody neutralisation of IL-22RA1 in cultured human islets leads to impaired insulin quality and increased cellular stress. Through the generation of mice lacking IL-22ra1 specifically on pancreatic alpha- or beta-cells, we demonstrate that ablation of murine beta-cell IL-22ra1 leads to similar decreases in insulin secretion, quality and islet regeneration, whilst increasing islet cellular stress, inflammation and MHC II expression. These changes in insulin secretion led to impaired glucose tolerance, a finding more pronounced in female animals compared to males. Our findings attribute a regulatory role for endogenous pancreatic beta-cell IL-22ra1 in insulin secretion, islet regeneration, inflammation/cellular stress and appropriate systemic metabolic regulation.

摘要

IL-22RA1 受体在胰腺中高度表达,外源性 IL-22 已被证明可减少人胰岛内质网和氧化应激,并促进β细胞分泌高质量的胰岛素。然而,IL-22RA1 信号在内分泌细胞上的内源性作用尚不清楚。在这里,我们表明,在培养的人胰岛中中和 IL-22RA1 的抗体导致胰岛素质量受损和细胞应激增加。通过生成特异性缺乏胰腺α或β细胞 IL-22ra1 的小鼠,我们证明了小鼠β细胞 IL-22ra1 的缺失导致胰岛素分泌、质量和胰岛再生减少,同时增加胰岛细胞应激、炎症和 MHC II 表达。这些胰岛素分泌的变化导致葡萄糖耐量受损,与雄性动物相比,雌性动物的这一发现更为明显。我们的研究结果表明,内源性胰腺β细胞 IL-22RA1 在胰岛素分泌、胰岛再生、炎症/细胞应激和适当的全身代谢调节中起调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/9680f2d40e7d/41467_2024_48320_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/ac9366221af1/41467_2024_48320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/e27755baa798/41467_2024_48320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/c9ee1209c149/41467_2024_48320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/2cb9c895d49a/41467_2024_48320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/65c3523a760e/41467_2024_48320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/7abdb2fe57d5/41467_2024_48320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/9680f2d40e7d/41467_2024_48320_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/ac9366221af1/41467_2024_48320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/e27755baa798/41467_2024_48320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/c9ee1209c149/41467_2024_48320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/2cb9c895d49a/41467_2024_48320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/65c3523a760e/41467_2024_48320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/7abdb2fe57d5/41467_2024_48320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f5d/11137127/9680f2d40e7d/41467_2024_48320_Fig7_HTML.jpg

相似文献

1
Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis.胰岛β细胞 IL-22 受体缺陷导致胰岛素生物合成和全身葡萄糖稳态的年龄依赖性失调。
Nat Commun. 2024 May 29;15(1):4527. doi: 10.1038/s41467-024-48320-2.
2
Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis.胰腺而非髓系细胞中白细胞介素-1α的表达对于维持胰岛素分泌和全身葡萄糖稳态是必需的。
Mol Metab. 2021 Feb;44:101140. doi: 10.1016/j.molmet.2020.101140. Epub 2020 Dec 5.
3
Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation.白细胞介素-1 受体在胰腺中的缺失破坏了全身葡萄糖稳态,并促进胰岛 β 细胞去分化。
Mol Metab. 2018 Aug;14:95-107. doi: 10.1016/j.molmet.2018.06.003. Epub 2018 Jun 6.
4
Loss of the voltage-gated proton channel Hv1 decreases insulin secretion and leads to hyperglycemia and glucose intolerance in mice.电压门控质子通道 Hv1 的缺失会减少胰岛素的分泌,导致小鼠高血糖和葡萄糖不耐受。
J Biol Chem. 2020 Mar 13;295(11):3601-3613. doi: 10.1074/jbc.RA119.010489. Epub 2020 Jan 16.
5
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.α1-抗胰蛋白酶改善胰岛淀粉样变诱导的葡萄糖不耐受和β细胞功能障碍。
Mol Metab. 2020 Jul;37:100984. doi: 10.1016/j.molmet.2020.100984. Epub 2020 Mar 27.
6
Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.抑制白细胞介素 1β反应性 miRNA-153 可预防β细胞衰竭和炎症相关的糖尿病。
Metabolism. 2020 Oct;111:154335. doi: 10.1016/j.metabol.2020.154335. Epub 2020 Aug 12.
7
Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis.胰腺α细胞衍生的胰高血糖素相关肽是β细胞适应和葡萄糖稳态所必需的。
Cell Rep. 2017 Mar 28;18(13):3192-3203. doi: 10.1016/j.celrep.2017.03.005.
8
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.糖尿病的血糖控制通过调节β细胞应激的细胞因子的治疗性操作来恢复。
Nat Med. 2014 Dec;20(12):1417-26. doi: 10.1038/nm.3705. Epub 2014 Nov 2.
9
Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice.游离脂肪酸受体 4 在δ细胞中的抑制性信号转导调节小鼠胰岛激素的分泌。
Mol Metab. 2021 Mar;45:101166. doi: 10.1016/j.molmet.2021.101166. Epub 2021 Jan 20.
10
Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance.抑制胰腺β细胞钙/钙调蛋白依赖性蛋白激酶 II 可减少葡萄糖刺激的钙内流和胰岛素分泌,损害葡萄糖耐量。
J Biol Chem. 2014 May 2;289(18):12435-45. doi: 10.1074/jbc.M114.562587. Epub 2014 Mar 13.

引用本文的文献

1
Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progression.评估IL22RA1表达作为人类结肠癌进展的预测指标。
BMC Cancer. 2025 Aug 7;25(1):1278. doi: 10.1186/s12885-025-14715-7.
2
Probiotic Supplementation Improves Glucose Homeostasis and Modulates Interleukin (IL)-21 and IL-22 Levels in Pediatric Patients with Type 1 Diabetes: A Randomized Placebo-Controlled Trial.补充益生菌可改善1型糖尿病患儿的血糖稳态并调节白细胞介素(IL)-21和IL-22水平:一项随机安慰剂对照试验
Metabolites. 2025 Apr 24;15(5):288. doi: 10.3390/metabo15050288.
3
Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside.

本文引用的文献

1
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis.靶向肝脏和胰腺的白细胞介素-22 作为治疗代谢功能障碍相关脂肪性肝炎的药物。
Nat Commun. 2024 May 29;15(1):4528. doi: 10.1038/s41467-024-48317-x.
2
Diabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity.糖尿病会加重饮食诱导肥胖小鼠的炎症性肠病。
World J Gastroenterol. 2023 Sep 7;29(33):4991-5004. doi: 10.3748/wjg.v29.i33.4991.
3
Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells.
治疗代谢功能障碍相关脂肪性肝病的分泌蛋白:从 bench 到 bedside
Protein Cell. 2025 Aug 7;16(8):641-666. doi: 10.1093/procel/pwaf027.
4
Innate immune cells link dietary cues to normal and abnormal metabolic regulation.先天性免疫细胞将饮食信号与正常和异常的代谢调节联系起来。
Nat Immunol. 2025 Jan;26(1):29-41. doi: 10.1038/s41590-024-02037-y. Epub 2025 Jan 2.
5
In Situ Expression of Yak in Mammary Glands as a Treatment for Bovine -Induced Mastitis in Mice.牦牛在乳腺中的原位表达作为治疗小鼠牛源性乳腺炎的方法。
Vet Sci. 2024 Oct 20;11(10):515. doi: 10.3390/vetsci11100515.
6
Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in the liver.肝脏白细胞介素22受体A1缺乏通过调节肝脏中的氧化甾醇促进肝脂肪变性。
Hepatology. 2025 May 1;81(5):1564-1582. doi: 10.1097/HEP.0000000000000998. Epub 2024 Jul 10.
7
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis.靶向肝脏和胰腺的白细胞介素-22 作为治疗代谢功能障碍相关脂肪性肝炎的药物。
Nat Commun. 2024 May 29;15(1):4528. doi: 10.1038/s41467-024-48317-x.
白细胞介素-22 抑制黏膜上皮细胞中的主要组织相容性复合体 II。
J Exp Med. 2023 Nov 6;220(11). doi: 10.1084/jem.20230106. Epub 2023 Sep 11.
4
IL-20 Activates ERK1/2 and Suppresses Splicing of X-Box Protein-1 in Intestinal Epithelial Cells but Does Not Improve Pathology in Acute or Chronic Models of Colitis.白细胞介素-20 通过激活 ERK1/2 并抑制肠道上皮细胞中 X 盒结合蛋白-1 的剪接,但不能改善急性或慢性结肠炎模型中的病理学。
Int J Mol Sci. 2022 Dec 22;24(1):174. doi: 10.3390/ijms24010174.
5
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes.胰岛内胰岛素合成缺陷与内质网应激及人类糖尿病中β细胞特征丧失有关。
Diabetologia. 2023 Feb;66(2):354-366. doi: 10.1007/s00125-022-05814-2. Epub 2022 Oct 25.
6
Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis.性别依赖性 IL-22 受体信号在非酒精性脂肪性肝病相关纤维化中的肝保护作用。
Cell Mol Gastroenterol Hepatol. 2022;14(6):1269-1294. doi: 10.1016/j.jcmgh.2022.08.001. Epub 2022 Aug 13.
7
Islet Gene View-a tool to facilitate islet research.胰岛基因观察——一种有助于胰岛研究的工具。
Life Sci Alliance. 2022 Aug 10;5(12):e202201376. doi: 10.26508/lsa.202201376.
8
The Role of IL-22 in Wound Healing. Potential Implications in Clinical Practice.IL-22 在伤口愈合中的作用。临床实践中的潜在意义。
Int J Mol Sci. 2022 Mar 28;23(7):3693. doi: 10.3390/ijms23073693.
9
Oxidative Stress Leads to β-Cell Dysfunction Through Loss of β-Cell Identity.氧化应激通过丧失β细胞特征导致β细胞功能障碍。
Front Immunol. 2021 Nov 4;12:690379. doi: 10.3389/fimmu.2021.690379. eCollection 2021.
10
Acetaminophen-Induced Liver Injury Exposes Murine IL-22 as Sex-Related Gene Product.对乙酰氨基酚诱导的肝损伤揭示了小鼠白介素-22 是一种性别相关的基因产物。
Int J Mol Sci. 2021 Sep 30;22(19):10623. doi: 10.3390/ijms221910623.